Jun. 23. 2020
Osaka, Japan - March 23, 2020 - Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) announced the launch dates with the below mentioned schedule for Vardenafil tablets (the branded product: LEVITRA®).
Vardenafil tablets are prescribed for the treatment of erectile dysfunction.
| Product Name | Launch Date |
|---|---|
| VARDENAFIL Tablets 10 mg [SAWAI] | July 6, 2020 |
| VARDENAFIL Tablets 20 mg [SAWAI] |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.